Mitral Valve Procedures in Hypertrophied Obstructive Cardiomyopathy (HOCM) Surgery

Background: Hypertrophic obstructive cardiomyopathy (HOCM) is a genetic illness where the left ventricle of the heart becomes abnormally thickened, resulting in significant hyper-trophy. Aim of Study: To review hypertrophic obstructive cardio-myopathy (HOCM), how to diagnose it, indications of treat-ment, medical management, and surgical management, in-cluding the technique, advantages, challenges, outcomes, and prognosis. Patients and Methods: This prospective research was per-formed on 100 cases with hypertrophied obstructive cardiomy-opathy (HOCM). Who are Medication-refractory symptoms that interfere with everyday activity or quality of life, despite maximal medical treatment consisting of beta blockers, calci-um channel blockers, or both, resting or provoked peak systolic LVOT gradient of 50mmHg or more, and the desired septal wall thickness necessary to effectively and safely carry out the treat-ment. (septal wall thickness ≥1.5cm). Results: There was a highly significant variance among be-fore and after surgery regarding NYHA grade, MR grade, SAM grade, septal thickness (mm), and LVOTG (mmHg) p<0.001, but a statistically insignificant variance was observed among preoperative and postoperatively regarding LVEF (%) p=0.08. Conclusion: Our analysis indicates that MV surgery in cas-es with hypertrophic obstructive cardiomyopathy leads to sig-nificant clinical enhancements with minimal mortality and mor-bidity. In cases of hypertrophic obstructive cardiomyopathy, mitral valve operation can effectively ease symptoms, relieve the LV outflow tract gradient, and resolve mitral regurgitation.